Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 117
Filter
1.
Gynecol Obstet Fertil ; 38(3): 199-204, 2010 Mar.
Article in French | MEDLINE | ID: mdl-20189438

ABSTRACT

More than 120 genotypes have been identified among the Papillomavirus (HPV) family. These viruses are ubiquitary with skin or mucous membrane tropism and cause various pathologies from wart to neoplasia. HPV family is classified according to their tropism. Genital HPV infection is considered as the most frequent sexually transmitted disease in the world. Seventy-five percent of women will be in contact with HPV at least one time in their life. HPV is usually transmitted through direct skin-to-skin contact, more often during penetrative genital contact. Other types of genital contact in the absence of penetration can lead to HPV infection, but those routes of transmission are much less common than sexual intercourse. However, virgins (<2 % of cases) and young children can present HPV infection, suggesting other routes of transmission than sexual intercourse. HPV infection could occur during delivery; vaginal deliveries appear to promote this transmission in comparison with cesarean section. But cesarean section do not completely protect against contamination risk. In utero, vertical transmission has been suggested by different studies but with lack of evidence. HPV infection can be detected on inanimate objects, such as clothing or environmental surfaces. However, transmission is not known to occur by this route. More detailed knowledges of the transmission route of HPV infection will enable to get prevention more effective.


Subject(s)
Papillomaviridae , Papillomavirus Infections/transmission , Cesarean Section , Coitus , Delivery, Obstetric , Female , Humans , Infectious Disease Transmission, Vertical , Milk, Human/virology , Papillomavirus Infections/epidemiology , Pregnancy , Sexually Transmitted Diseases, Viral/transmission , Uterine Cervical Diseases/virology
2.
J Gynecol Obstet Biol Reprod (Paris) ; 39(2): 102-15, 2010 Apr.
Article in French | MEDLINE | ID: mdl-20106606

ABSTRACT

OBJECTIVES: Analysis of the trials which compare the virologic testing (HPV testing) and the cytology in the cervical screening. MATERIAL AND METHODS: The MedLine database was consulted using the Keywords: "cervical screening", "pap smear", "liquid based cytology", "HPV testing", "adults", "adolescents", "cervical intraepithelial neoplasia (CIN)", "uterine cervix cancer". Articles were selected according their concern about the debate of the uterine cervix cancer screening in France. RESULTS: The HPV testing seems interesting allowing a decreasing delay in the diagnosis of CIN (more diagnosis of CIN2+ in the first round and less during the second one). But, when the two rounds are added, the number of CIN2+ are identical in the two arms (cytology and HPV testing) in all the trials (except the Italian NTCC trial). A negative HPV testing protects the women much longer than cytology can do: a delay of five years between two rounds seems ideal. The HPV testing alone increases the detection rate of cervical lesions, which could regress spontaneously and may induce an overtreatment, especially in the youngest population: a triage is necessary and the cytology appears to be the best way to select the candidates for colposcopy in case of positive HPV testing and cytology. The HPV infection presents some particularities in adolescent females: for this reason, the HPV testing should not be used in this special population. In vaccinated women, a consensus for the screening is necessary. CONCLUSION: The health care providers in France have to understand the characteristics of the HPV testing: its advantages compared to the cytologic screening are only evident in case of an organization of the screening in France and even in Europe.


Subject(s)
Mass Screening/methods , Papanicolaou Test , Papillomaviridae/isolation & purification , Uterine Cervical Neoplasms/diagnosis , Uterine Cervical Neoplasms/prevention & control , Vaginal Smears , Adolescent , Adult , Europe , Female , France , Humans , Mass Screening/economics , Papillomavirus Infections/diagnosis , Papillomavirus Infections/virology , Papillomavirus Vaccines , Randomized Controlled Trials as Topic , Time Factors , Uterine Cervical Neoplasms/virology , Uterine Cervical Dysplasia/diagnosis , Uterine Cervical Dysplasia/virology
6.
J Gynecol Obstet Biol Reprod (Paris) ; 37(8): 811-4, 2008 Dec.
Article in French | MEDLINE | ID: mdl-18653292

ABSTRACT

The evolution of pregnancies following uterine-artery embolisation (UAE) for symptomatic fibroids remains uncertain. We report a case of pregnancy after UAE, complicated of adherent placenta with uterine rupture, in a context of uterine leiomyomata with a prior cesarean delivery. Through a recent review of the literature, we discuss the main obstetrical complications following UAE. Appropriate management of these high-risk pregnancies, notably in case of risk of adherent placenta, seems to be necessary.


Subject(s)
Leiomyoma/therapy , Placenta Accreta/etiology , Uterine Artery Embolization , Uterine Neoplasms/therapy , Uterine Rupture/etiology , Adult , Female , Humans , Leiomyoma/blood supply , Pregnancy , Pregnancy Complications, Neoplastic , Pregnancy Outcome , Pregnancy, High-Risk , Uterine Hemorrhage/etiology , Uterine Neoplasms/blood supply
7.
Gynecol Obstet Fertil ; 36(6): 616-22, 2008 Jun.
Article in French | MEDLINE | ID: mdl-18539502

ABSTRACT

OBJECTIVE: The aim of this study is to assess the results of conservative management of adenocarcinoma in situ (AIS) of the uterine cervix. PATIENTS AND METHODS: Retrospective multicentric study with 121 cases. Patients with cervical invasive lesions were excluded. General characteristics of population, diagnosis circumstances, treatment, histology and evolution were studied. RESULTS: Conservative treatment was performed in 98.3% of cases with 64% of negative margins. In the positive margins group, 80% of conservative treatments were performed by electrosurgical loop. Length of cone resection is significantly higher for conization with negative margins (p<0.001). The rate of residual lesion was 18% in negative margins group and 46% in positive margins group. Two noninvasive and one invasive recurrence were deplored. DISCUSSION AND CONCLUSION: Conservative surgery for patients with AIS could be considered in young patients but several conditions should be respected: careful follow-up after conservative treatment; cold knife conization; length of cone specimen greater than 25 mm and negative margins.


Subject(s)
Adenocarcinoma/surgery , Carcinoma in Situ/surgery , Neoplasm Recurrence, Local/prevention & control , Papillomavirus Infections/surgery , Uterine Cervical Neoplasms/surgery , Adenocarcinoma/pathology , Adult , Age Factors , Aged , Carcinoma in Situ/pathology , Female , Humans , Middle Aged , Neoplasm Recurrence, Local/epidemiology , Neoplasm Staging , Papillomavirus Infections/pathology , Retrospective Studies , Risk Assessment , Treatment Outcome , Uterine Cervical Neoplasms/pathology
8.
Gynecol Obstet Fertil ; 35(9): 776-9, 2007 Sep.
Article in French | MEDLINE | ID: mdl-17766164

ABSTRACT

We report a case of a vulvar invasive squamous cell carcinoma associated to a benign tumor with apocrine differenciation, the hidradenoma papilliferum, infiltrated by the carcinoma. Diagnosis was established by clinical and histopathological examination, first on biopsy and then on local vulvar excision. Classical association between hidradenoma papilliferum and Paget's disease is described, but to the best of our knowledge, there have been no previous reports of such case in published literature. A common physiopathological etiology cannot be completely excluded.


Subject(s)
Adenoma, Sweat Gland/pathology , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/surgery , Vulvar Neoplasms/secondary , Aged , Biopsy , Female , Humans , Neoplasm Invasiveness , Vulvar Neoplasms/pathology , Vulvar Neoplasms/surgery
9.
Prenat Diagn ; 27(6): 552-4, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17345584

ABSTRACT

We report the case of monozygotic (MZ) male twin fetuses with different Down syndrome (DS) phenotypes. Prenatal fetal sonography showed a bichorial biamniotic pregnancy with increased nuchal translucency in twin A and a cervical cystic hygroma and heart defect in twin B. Cytogenetic analysis performed after double amniocentesis showed free and homogeneous trisomy 21 in both twins. Monozygosity was confirmed by molecular analysis. The pregnancy was terminated at 17 weeks of gestation (WG). Postmortem analysis confirmed the phenotypic discordance. To our knowledge, this is the first reported prenatal diagnosis of MZ male twins with different Down syndrome phenotypes but identical karyotypes. We discuss the mechanisms involved in phenotypic discordance of monozygotic twins and particularly the role of environmental factors.


Subject(s)
Diseases in Twins/diagnostic imaging , Down Syndrome/diagnostic imaging , Twins, Monozygotic , Ultrasonography, Prenatal , Abortion, Induced , Female , Humans , Male , Phenotype , Pregnancy
10.
Article in French | MEDLINE | ID: mdl-17293257

ABSTRACT

The surgical treatment of the stress urinary incontinence mainly use tension free vaginal tape done through the Retzius space: a case of bladder erosion occurring 5 years after a TVT (Gynecare-Ethicon, USA) procedure is reported. First clinical signs occur 2 years after the operation and the removal of the tape (included in the muscle of the bladder) by vaginal and sus-pubic route was necessary 5 years later because the quality of life was dramatically altered. This complication could be related to the patient (past hysterectomy, history of fibrosis surrounding a mammary implant, Gougerot-Sjögren disease) or to the surgeon with a technical defect during the TVT procedure. The late complications of TVT procedure should be recorded in a national register.


Subject(s)
Device Removal , Urinary Bladder/pathology , Urinary Incontinence, Stress/surgery , Urogenital Surgical Procedures/adverse effects , Urogenital Surgical Procedures/methods , Female , Humans , Middle Aged , Prosthesis Implantation , Quality of Life
11.
Gynecol Obstet Fertil ; 35(2): 125-8, 2007 Feb.
Article in French | MEDLINE | ID: mdl-17218143

ABSTRACT

We report the case of a patient presenting multiple recurrent papillomas of the breast. This mild mammary pathology, developed at the expense of the galactophoric ducts, recurred four times, in a nodular way, in spite of in sano surgical resection. The retrospective study of the cell proliferation and the DNA quantification of the cells constitutive of the papillomas, on several samples, underlined evolutive lesions, which could be predictive of a malignant degeneration. This observation allows us to discuss the management of this rare mild mammary pathology, which can sometimes lead to invasive breast carcinoma.


Subject(s)
Breast Neoplasms/diagnosis , Breast/pathology , Papilloma/diagnosis , Adult , Breast/surgery , Breast Neoplasms/surgery , Cell Division , DNA, Viral/analysis , Female , Humans , Neoplasm Recurrence, Local/surgery , Papilloma/surgery , Retrospective Studies
12.
Gynecol Obstet Fertil ; 34(12): 1178-84, 2006 Dec.
Article in French | MEDLINE | ID: mdl-17097907

ABSTRACT

The management of adenocarcinoma in situ of the cervix (ACIS) is difficult because it is often diagnosed in younger women who may wish to preserve their potential of fertility. Conservative treatment has been accepted as an appropriate strategy but interrogations persist as to carcinological safety. We report a complete review of the literature on this subject where conservative attitude appears possible but is associated with recurrence risk (5 to 10%) and invasive disease (2%). Conditions to perform conservative management are: cold knife cone biopsy, negative margins, cone resection of at least 25 mm, realization of endocervical curettage and total patient compliance. In all cases, regular cytological and histological monitoring must be performed. If maintaining reproductive capacity is not desired, hysterectomy is systematically proposed to patient.


Subject(s)
Adenocarcinoma/surgery , Carcinoma in Situ/surgery , Colposcopy/methods , Reproduction , Uterine Cervical Neoplasms/surgery , Female , Humans , Hysterectomy/methods , Neoplasm Recurrence, Local/prevention & control , Neoplasm Recurrence, Local/surgery , Reproduction/physiology
13.
Int J Gynecol Cancer ; 16(5): 1911-7, 2006.
Article in English | MEDLINE | ID: mdl-17009991

ABSTRACT

Matrix metalloproteinase (MMPs) expression has been linked to gynecological tumor aggressiveness. The objective of this study was to determine MMP-2, MMP-7, and MMP-9 and tissue inhibitors of metalloproteinases (TIMP)-1 and TIMP-2 expression in endometrial malignancies and their relation to clinical and histologic parameters. Formalin-fixed, paraffin-embedded tumor samples from 50 patients with endometrial carcinoma treated between 1999 and 2004 were stained with specific monoclonal antibodies. The tumors were grouped according to the FIGO classification. The staining results were compared to histologic and clinical data. Semiquantitative analysis of MMP and TIMP expression showed a significant difference in TIMP-2 expression according to the histologic subtype (P = 0.03) and also a trend towards a difference in MMP-9 expression (P = 0.05). MMP-2 expression increased and TIMP-2 expression fell as the histologic grade increased (P = 0.0007, P < 0.0001, respectively). MMP-2 expression correlated with lymph node metastasis (P = 0.04), while TIMP-2 expression correlated with the depth of myometrial invasion (P = 0.01), vasculolymphatic space involvement (P = 0.02), and lymph node metastasis (P = 0.0003). These results support the involvement of MMPs and TIMPs in endometrial tumor growth and progression. High MMP-2 and low TIMP-2 expression were the most potent markers of endometrial tumors with a high risk of local and distant spread.


Subject(s)
Carcinoma/metabolism , Endometrial Neoplasms/metabolism , Matrix Metalloproteinase 2/metabolism , Tissue Inhibitor of Metalloproteinase-2/metabolism , Carcinoma/pathology , Endometrial Neoplasms/pathology , Endometrium/pathology , Female , Gene Expression Regulation, Enzymologic , Gene Expression Regulation, Neoplastic , Humans , Matrix Metalloproteinase 7/metabolism , Matrix Metalloproteinase 9/metabolism , Neoplasm Invasiveness , Tissue Inhibitor of Metalloproteinase-1/metabolism
14.
Gynecol Obstet Fertil ; 34(6): 510-3, 2006 Jun.
Article in French | MEDLINE | ID: mdl-16697688

ABSTRACT

Abnormalities of the reproductive tract interest a little more than 1% of the women. The symptoms are not specific: abdominal pain seems like appendicitis, invalidating dysmenorrheas in the girl, urinary manifestations. They should be discovered and treated because they could bring about obstetric complications later. We present three observations, illustrated with a recent review of the literature, and describe the diagnostic difficulties and their surgical treatments.


Subject(s)
Hematocolpos/etiology , Vagina/abnormalities , Abdominal Pain , Adult , Child , Dysmenorrhea , Female , Hematocolpos/diagnosis , Hematocolpos/surgery , Humans , Ultrasonography , Vagina/diagnostic imaging , Vagina/surgery
15.
Gynecol Obstet Fertil ; 34(2): 131-3, 2006 Feb.
Article in French | MEDLINE | ID: mdl-16442327

ABSTRACT

Acute fatty liver of pregnancy is a rare clinical syndrome of pregnancy that occurs during the third trimester. Clinicians must have a high index of suspicion for this condition when a woman has nausea or vomiting during the last trimester. Early diagnosis and prompt delivery improve foetal and maternal prognosis. We report a case of a previously healthy 23-year-old woman who presented an acute fatty liver of pregnancy with intrauterine fetal death. Based on this experience as well as on medical literature, characteristics of this uncommon pathology are discussed.


Subject(s)
Fatty Liver/complications , Fatty Liver/diagnosis , Fetal Death/etiology , Pregnancy Complications/diagnosis , Acute Disease , Adult , Fatty Liver/etiology , Female , Humans , Pregnancy , Pregnancy Complications/etiology , Pregnancy Trimester, Third
16.
Maturitas ; 53(3): 299-305, 2006 Feb 20.
Article in English | MEDLINE | ID: mdl-16043317

ABSTRACT

OBJECTIVES: The aim of the study was to confirm the endometrial safety and describe the bleeding profile of continuous combined 1 mg 17beta-oestradiol and 5 mg dydrogesterone in post-menopausal women. METHODS: An open, multicentre study was carried out in 290 healthy, non-hysterectomised post-menopausal women receiving oral continuous combined 1 mg 17beta-oestradiol and 5 mg dydrogesterone (Femoston-conti) for 1 year. Aspiration endometrial biopsies were performed at baseline and at the end of the study; those classified as hyperplasia or malignancy were considered treatment failures. RESULTS: Only one woman developed simple hyperplasia without atypia at the end of the study; the treatment failure rate was therefore 0.4%. Cross-sectional analysis showed that the percentage of women without bleeding increased from 71% during the first cycle to around 80% by the end of the study. Approximately 50% of the bleeding episodes occurred in the form of spotting; severe bleeding was rare and only seven women withdrew prematurely from the study due to uterine bleeding. Overall, 41% of the women were amenorrhoeic throughout the study. CONCLUSIONS: Continuous combined 1 mg 17beta-oestradiol and 5 mg dydrogesterone provides excellent endometrial safety and is associated with an acceptable bleeding profile.


Subject(s)
Dydrogesterone/administration & dosage , Endometrium/drug effects , Estradiol/administration & dosage , Estrogen Replacement Therapy , Postmenopause , Uterine Hemorrhage/chemically induced , Aged , Cross-Sectional Studies , Drug Combinations , Drug-Related Side Effects and Adverse Reactions , Dydrogesterone/adverse effects , Estradiol/adverse effects , Female , Humans , Middle Aged , Treatment Outcome
18.
J Gynecol Obstet Biol Reprod (Paris) ; 34(6): 529-56, 2005 Oct.
Article in French | MEDLINE | ID: mdl-16208197

ABSTRACT

Since the introduction of hormonal contraceptives in the 1960s, great advances have been achieved in contraception. Biological effects of sexual steroids as well as risks and benefits of oral contraception are better estimated. After the development of a new hormone-containing intra-uterine system, new hormone delivery systems offer women safe and effective contraceptive options. These new options that combine high efficacy and ease of use should allow better acceptance and compliance than daily pill ingestion and should then reduce the high rate of unintended pregnancies terminated by elective abortion. Transdermal contraceptive system and vaginal ring offer a promising innovative approach in pregnancy prevention. Subdermal implants give women the choice of a highly effective contraceptive system in spite of significant side effects. New hormonal delivery systems such as injectables are under development. Hysteroscopic tubal sterilization is now also available and is a very effective procedure. This wide variety of new contraceptive methods offers a marked improvement from previous medications for users by providing better efficacy and tolerability.


Subject(s)
Contraception/trends , Adolescent , Adult , Contraception/methods , Contraception, Postcoital , Contraceptive Agents/administration & dosage , Contraceptive Agents/adverse effects , Contraceptives, Oral, Combined/administration & dosage , Contraceptives, Oral, Combined/adverse effects , Estrogens/administration & dosage , Estrogens/adverse effects , Female , Humans , Intrauterine Devices/adverse effects , Pregnancy , Progestins/administration & dosage , Progestins/adverse effects
19.
Histol Histopathol ; 20(4): 1085-91, 2005 10.
Article in English | MEDLINE | ID: mdl-16136491

ABSTRACT

The aim of the present work was to evaluate the usefulness of high-risk human papillomavirus (HR-HPV) testing for the follow-up of women with untreated low grade cervical squamous cell lesions (LSIL). For that, 412 women with a cytological diagnosis of LSIL at entry were monitored by cytology, HR-HPV testing with the Hybrid Capture II assay (HC-II) and colposcopy. Our primary endpoint was clinical progression defined by the presence of a high grade cervical intraepithelial neoplasia (CIN2 and CIN3) at the biopsy. At baseline, histological control revealed 10 CIN2 and 11 CIN3 only in the cohort of women HR-HPV+. In the follow-up, 4 CIN2 and 8 CIN3 were detected, always in the women initially HR-HPV+. Thus, the recurrence of a HR-HPV+ infection clearly selects a population at high-risk for CIN2-3. The semi-quantitative appreciation of the viral load with HC-II could not be used as a good prognostic factor for the follow-up of women with LSIL. HR-HPV testing reduces the number of cytology and colposcopy examinations in the follow-up of women aged >35 years when HPV testing is initially negative. Thus HR-HPV testing should be reserved for the follow-up of this population of women initially HR-HPV+ and proposed 6 to 12 months after the cytological diagnosis of LSIL.


Subject(s)
Cervix Uteri/pathology , Cervix Uteri/virology , Papillomaviridae/isolation & purification , Papillomavirus Infections/diagnosis , Adolescent , Adult , Aged , Carcinoma, Squamous Cell/diagnosis , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/virology , Cervix Uteri/cytology , Endothelium/pathology , Female , Follow-Up Studies , Humans , Middle Aged , Papillomavirus Infections/pathology , Papillomavirus Infections/virology , Risk Factors , Uterine Cervical Neoplasms/diagnosis , Uterine Cervical Neoplasms/pathology , Uterine Cervical Neoplasms/virology
20.
J Clin Pathol ; 58(8): 864-71, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16049291

ABSTRACT

BACKGROUND: HER-2 amplification is an important prognostic biomarker and treatment determinant in breast carcinoma. AIMS: To correlate immunocytochemical (ICC) expression of HER-2 and gene amplification determined by chromogenic in situ hybridisation (CISH) using liquid based cytology (LBC) with immunohistochemistry (IHC) and CISH using histological samples of the same breast carcinomas. METHODS: Frozen sections and cytobrushings of 103 breast carcinomas were analysed. Four techniques were performed on each tumour: two on LBC samples (ICC, and CISH, both graded as positive, indeterminate, or negative) and two on histological samples (IHC and CISH). Two cell lines (MCF-7, negative; BT 474, positive) were used as controls for cytological analysis. A complementary fluorescence in situ hybridisation technique was carried out in histological samples with low amplification (4-10 dots/nucleus). RESULTS: Interobserver agreement for the four techniques calculated by the kappa coefficient indicated a substantial agreement. Nine cases failed in cytology because of poor cellularity. Among 94 cases, 19 were amplified; 73, 12, and 9 tumours were scored 0 or 1+, 2+, and 3+, respectively by IHC and 75, 13, and 6, respectively, by ICC. CISH found no amplification in 72 tumours. Correlations between the IHC and CISH results in the histological and cytological samples were always significant. CONCLUSIONS: Her-2 status could be determined in LBC samples and correlated well with reference histological methods using in situ hybridisation. ICC was less reliable because of the presence of the cytoplasmic membrane. However, these results should be confirmed by a large multicentre study.


Subject(s)
Biomarkers, Tumor/metabolism , Breast Neoplasms/metabolism , Receptor, ErbB-2/metabolism , Adult , Aged , Aged, 80 and over , Breast Neoplasms/genetics , Breast Neoplasms/pathology , Carcinoma, Ductal/genetics , Carcinoma, Ductal/metabolism , Carcinoma, Ductal/pathology , Female , Genes, erbB-2 , Humans , Immunoenzyme Techniques , In Situ Hybridization , In Situ Hybridization, Fluorescence , Middle Aged , Neoplasm Proteins/metabolism , Prognosis , Prospective Studies , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...